TransUnion

NYSE:TRU

Consulting Services

Industrials
$75.82 -6.50%

-$4.48 today

Market cap
$14.46B
Beta
1.55
P/E (TTM)
17.6
EPS (TTM)
$3.66
Dividend yield
0.74%
52W Low $63.96High $99.39

Volume 2.45M

Average 2.19M

TRU Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

TransUnionNYSE: TRU

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development remains negative

Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMJun 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How TRU compares with its peers on the latest reported figures

  • TRU's LTM Jun 2026 research & development of $0 is the 2nd highest of the 6 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for TRU, versus a peer median of 0.0%.
TRU Competitors Peer median
Research & Development for TRU and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FICOFair Isaac CorporationLTM Jun 2026$208.49M +14.8%+8.7%8.7%
TRUTransUnionLTM Jun 2026$0 ——0.0%
SPGIS&P Global Inc.LTM Jun 2026$0 ——0.0%
MCOMoody's CorporationLTM Sep 2026$0 ——0.0%
VRSKVerisk Analytics, Inc.LTM Jun 2026$0 ——0.0%
EFXEquifax Inc.LTM Sep 2026$0 ——0.0%
Peer median (excluding TRU) $0+14.8%+8.7%0.0%

Competitors are the stored peer set for TRU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.96B3.71B3.83B4.18B4.58B
Cost of Revenue1.02B1.39B1.52B1.67B1.87B
Gross Profit1.94B2.32B2.31B2.51B2.7B
Gross Margin65.5%62.7%60.4%60.0%59.1%
Research & Development00000
Selling, General & Admin909M1.15B1.17B1.24B1.26B
Operating Expenses1.29B1.7B2.19B1.84B1.85B
Depreciation & Amortization377M519M524.4M537.8M574.8M
EBITDA995.2M1.13B667.3M1.2B1.45B
EBITDA Margin33.6%30.5%17.4%28.8%31.8%
Operating Income651.9M626.3M128.5M666.7M857.8M
Operating Margin22.0%16.9%3.4%15.9%18.7%
Interest Income3.4M4.7M20.7M28.5M33.2M
Interest Expense132.2M230.9M288.2M265.2M235.8M
Other Income / Expenses(146.3M)(243.3M)(273.8M)(265.6M)(214.8M)
Income Before Tax505.6M383M(145.3M)401.1M643M
Pre-Tax Margin17.1%10.3%-3.8%9.6%14.1%
Income Tax Expense131.9M118.9M44.7M98.8M173.1M
Net Income1.39B266.3M(206.2M)284.4M455.4M
Net Margin47.0%7.2%-5.4%6.8%10.0%
EPS (Basic)7.251.40(1.07)1.462.34
EPS (Diluted)7.191.40(1.07)1.452.32
Weighted Avg Shares191.4M192.5M193.4M194.4M194.4M
Weighted Avg Shares (Diluted)193M193.1M193.4M196.7M196.6M

TransUnion

NYSE:TRU

Intrinsic Alpha fair value

Locked

Current Price

$75.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.